BioCentury
ARTICLE | Financial News

Moderna raises $604M in record IPO, loses $1.4B in trading debut

December 14, 2018 8:13 PM UTC

Moderna Inc. (NASDAQ:MRNA) tumbled out of the gate on Dec. 7, losing $4.40 (19%) to $18.60 in its trading debut for a loss of $1.4 billion in market cap as U.S. stocks across the board closed sharply lower.

On Dec. 6, the mRNA company set the record for the largest NASDAQ IPO for a biotech when it raised $604.3 million in an upsized offering through the sale of 26.3 million shares at $23. The deal gave Moderna a postmoney valuation of $7.6 billion...

BCIQ Company Profiles

Moderna Inc.